Alnylam Pharmaceuticals
ALNY
#622
Rank
C$45.98 B
Marketcap
$356.55
Share price
-1.16%
Change (1 day)
40.04%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company